KoinLensby LoLMinds
Coin Directory
Eli Lilly (Ondo Tokenized Stock) logo

Eli Lilly (Ondo Tokenized Stock)LLYON

Rank #1598Ethereum
41/ 100

KoinLens ScoreWeak

Overall analytical assessment — project quality, asset performance, market health and risk.

Performance

59

60% weight

Trust & Safety

15

40% weight

0Band thresholds at 20 · 40 · 60 · 75 · 90100

82% of the indicators behind this score were evaluated from real data — the rest are estimated, so treat the number as approximate.

Measured (13)

  • Contract Security
  • Liquidity & Lock
  • Holder Distribution
  • Tokenomics
  • Volume Quality
  • Exchange Listings
  • Community & Ecosystem
  • Capital Preservation
  • vs Bitcoin
  • Scale & Durability
  • Price Structure
  • Dilution Risk
  • Recent Trend

Estimated (4)

  • Developer Activity
  • Team Transparency
  • Age & Survival
  • Revenue & Usage

Estimated indicators still affect the score — the input was unavailable, so a neutral value stood in for it. We show which ones rather than presenting the number as complete.

Eli Lilly (Ondo Tokenized Stock) scores 41/100 on KoinLens (Weak) — 59/100 on performance and survival, 15/100 on trust and safety. Performance carries the most weight because a project can be entirely legitimate and still have lost most of its value. These are transparent, rule-based signals about the past — not a forecast, and not financial advice.

Relative performance

vs Bitcoin (1y)-26.4%· market is bear

Measured against Bitcoin because in a market where everything falls together, falling is not informative — losing ground relative to the benchmark is. Underperforming Bitcoin during a Bitcoin-led cycle does not by itself mean the project is unhealthy.

It is an overall analytical assessment of project quality, asset performance, market health and risk — a summary of the sections below, not a separate judgement.

It is not a probability, a percentage chance of success, a price target, or a recommendation to buy or sell. KoinLens knows nothing about your time horizon, entry price, position size or tax situation.

Mechanically it blends performance and survival (60%) with trust and safety (40%), then applies factual ceilings so that no amount of good paperwork can lift a coin that has lost most of its value. Not financial advice.

KoinLens Score v2.0 · rule-based signals · updated Sep 2, 2026· not financial advice

At a glance

Every dimension, one screen

Research lenses reweight the same evidence for a different question. Scores below them are the dimensions those lenses draw on. Tap any section further down for the full working.

Research lenses

Long-Term

54/100

Weak

Short-Term

70/100

Moderate

Trading

52/100

Weak

Fundamentals

46/100

Weak

Scores

TrustEST

45/100

Weak

Security

53/100

Weak

FundamentalsEST

45/100

Weak

Performance

72/100

Moderate

Market Health

37/100

High Risk

Momentum

88/100

Strong

Lenses are research views, not recommendations — KoinLens knows nothing about your time horizon, entry price or position size.

Verdict

Is Eli Lilly (Ondo Tokenized Stock) a scam? Is it safe?

Eli Lilly (Ondo Tokenized Stock) (LLYON) scores 41/100 on KoinLens — Weak.

Is Eli Lilly (Ondo Tokenized Stock) a scam?
KoinLens has found no automated red flags marking Eli Lilly (Ondo Tokenized Stock) (LLYON) as a scam. It scores 41/100 (Weak), a middling result. It trades 10% below its all-time high. Verify the contract on official channels and check liquidity before trading.
Is Eli Lilly (Ondo Tokenized Stock) safe to buy?
Eli Lilly (Ondo Tokenized Stock) scores 41/100 on KoinLens (Weak). It trades 10% below its all-time high. That reflects real, measurable weakness — most often a deep drawdown, sustained underperformance against Bitcoin, or thin liquidity. Size any position carefully and never invest more than you can afford to lose. This is a signal, not financial advice.
Is Eli Lilly (Ondo Tokenized Stock) legit?
Eli Lilly (Ondo Tokenized Stock) appears to be a real, tracked and tradeable cryptocurrency ranked #1598 — "legitimate" and "a good investment" are separate questions, and KoinLens answers both separately. Its score of 41/100 (Weak) reflects weak performance and/or risk signals, it trades 10% below its all-time high. rather than proof of anything dishonest. Research the team, the use case and the token's supply schedule before trusting it.

KoinLens rates Eli Lilly (Ondo Tokenized Stock) at 41/100 (Weak), from a transparent, rule-based blend weighted 60% toward performance — drawdown, how long it has been underwater and how it has fared against Bitcoin — and 40% toward trust signals such as contract security, liquidity, holder distribution, team transparency and exchange listings. Bitcoin is the benchmark every other coin is measured against. These are transparent, rule-based signals about the past — not human opinion, not a forecast, and not financial advice.

Unlock the full report

See the KoinLens Score breakdown, verdict, investment-decision panel and security checks — free with an account.

Already have an account?